EUVIMEDEUVIMED entdecken
Crossref

Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy

Jinmei Lai, Qunying Shi, Yongqi Xie, Yinyin Zhu, Shiyu Liang, Yi Chen, Jiali Yuan, Lihan Liu iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Jinmei Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceuti…. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumoral thermal defense mechanisms considerably attenuate the therapeutic outcomes of mild-temperature photothermal therapy (PTT). Thus, developing a simple, efficient, and universal therapeutic strategy to sensitize mild-temperature PTT is desirable. Herein, we report self-delivery nanomedicines ACy NPs comprising a near-infrared (NIR) photothermal agent (Cypate), mitochondrial oxidative phosphorylation inhibitor (ATO), and distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG2000), which have a high drug-loading efficiency that can reverse tumoral thermal resistance, thereby increasing mild-temperature PTT efficacy. ACy NPs achieved targeted tumor accumulation and performed NIR fluorescence imaging capability in vivo to guide tumor PTT for optimized therapeutic outcomes. The released ATO reduced intracellular ATP levels to downregulate multiple heat shock proteins (including HSP70 and HSP90) before PTT, which reversed the thermal resistance of tumor cells, contributing to the excellent results of mild-temperature PTT in vitro and in vivo. Therefore, this study provides a simple, biosafe, advanced, and universal heat shock protein-blocking strategy for tumor PTT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperthermia, InducedNeoplasmsNanoparticlesHumansPhotothermal TherapyNanomedicinePhototherapyTemperatureCell Line, Tumor

Stichwörter der Autor:innen

heat shock protein inhibitionmild-temperature photothermal therapymitochondrial oxidative phosphorylation inhibitorself-assemblythermal resistancetumor therapy

Autor:innen und Institutionen

  • NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong510515,…

ORCID-Profile: Lihan Liu

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Lai, J., Shi, Q., Xie, Y., Zhu, Y., Liang, S., Chen, Y., Yuan, J., & Liu, L. (2024). Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01217

Vancouver

Lai J, Shi Q, Xie Y, Zhu Y, Liang S, Chen Y, et al. Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01217

BibTeX
@article{Lai2024,
  author = {Lai, Jinmei and Shi, Qunying and Xie, Yongqi and Zhu, Yinyin and Liang, Shiyu and Chen, Yi and Yuan, Jiali and Liu, Lihan},
  title = {Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01217}
}
Kostenlos starten →